Evidence map›Paper›PMID 25243150›Full record

ArticleBioMed research international2014

Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone.

Giovanna Zacchetti, Romain Dayer, René Rizzoli, Patrick Ammann

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Do antiosteoporotic drugs improve bone regeneration in vivo?European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2020
    Article
  9. Article
  10. Article
  11. Strontium Ranelate Combined with Insulin Is as Beneficial as Insulin Alone in Treatment of Fracture Healing in Ovariectomized Diabetic Rats.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  12. Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giovanna ZacchettiDivision of Bone Disease, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.
Romain DayerDivision of Bone Disease, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.ORCID 0000-0001-5439-4226
René RizzoliDivision of Bone Disease, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.
Patrick AmmannDivision of Bone Disease, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.ORCID 0000-0002-7150-2433
University Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid bone defect filling with normal bone is a challenge in orthopaedics and dentistry. Strontium ranelate (SrRan) has been shown to in vitro decrease bone resorption and increase bone formation, and represents a potential agent with the capacity to accelerate bone defect filling. In this study, bone tibial defects of 2.5 mm in diameter were created in 6-month-old female rats orally fed SrRan (625 mg/kg/d; 5/7 days) or vehicle for 4, 8, or 12 weeks (10 rats per group per time point) from the time of surgery. Tibias were removed. Micro-architecture was determined by micro-computed tomography (µCT) and material level properties by nanoindentation analysis. µCT analysis showed that SrRan administration significantly improved microarchitecture of trabecular bone growing into the defect after 8 and 12 weeks of treatment compared to vehicle. SrRan treatment also accelerated the growth of cortical bone over the defect, but with different kinetics compared to trabecular bone, as the effects were already significant after 4 weeks. Nanoindentation analysis demonstrated that SrRan treatment significantly increased material level properties of both trabecular bone and cortical bone filling the defect compared to vehicle. SrRan accelerates the filling of bone defect by improving cortical and trabecular bone microarchitecture both quantitatively and qualitatively.

Indexed as

Administration, OralAnimalsBone Density Conservation AgentsFemaleInsulin-Like Growth Factor IOsteogenesisRatsRats, Sprague-DawleyThiophenesTibiaWound HealingX-Ray MicrotomographyBone Density Conservation AgentsInsulin-Like Growth Factor Istrontium ranelateThiophenes

Identifiers

PMID25243150
PMCPMC4163478
OpenAlexW2107476425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.